Evidence map›Paper›PMID 30358839›Full record

ArticleJournal of animal science2018

Effects of chlortetracycline alone or in combination with direct fed microbials on nursery pig growth performance and antimicrobial resistance of fecal Escherichia coli.

Hayden E Williams, Mike D Tokach, Steve S Dritz, Jason C Woodworth, Joel M DeRouchey, Tiruvoor G Nagaraja, Robert D Goodband, John R Pluske, Kessinee Chitakasempornkul, Nora M Bello and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of animal science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Hayden E WilliamsDepartment of Animal Sciences and Industry, College of Agriculture, Manhattan, KS.
Mike D TokachDepartment of Animal Sciences and Industry, College of Agriculture, Manhattan, KS.
Steve S DritzDepartment of Diagnostic Medicine/Pathobiology College of Veterinary Medicine, Manhattan, KS.
Jason C WoodworthDepartment of Animal Sciences and Industry, College of Agriculture, Manhattan, KS.
Joel M DeRoucheyDepartment of Animal Sciences and Industry, College of Agriculture, Manhattan, KS.
Tiruvoor G NagarajaDepartment of Diagnostic Medicine/Pathobiology College of Veterinary Medicine, Manhattan, KS.
Robert D GoodbandDepartment of Animal Sciences and Industry, College of Agriculture, Manhattan, KS.
John R PluskeSchool of Veterinary and Life Sciences, Murdoch University, Murdoch, WA, Australia.
Kessinee ChitakasempornkulDepartment of Statistics, College of Arts and Sciences, Kansas State University, Manhattan, KS.
Nora M BelloDepartment of Statistics, College of Arts and Sciences, Kansas State University, Manhattan, KS.
Raghavendra G AmachawadiDepartment of Clinical Sciences, Manhattan, KS.
Center for Grain and Animal Health Research · USKansas State University · USManhattan High School · USMurdoch University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A total of 300 nursery pigs (initially 5.9 ± 0.05 kg BW) were used in a 42-d growth trial to evaluate the effects of feeding a therapeutic level of chlortetracycline (CTC) with or without direct fed microbials (DFM) on growth performance and antimicrobial resistance (AMR) of fecal Escherichia coli. CTC is a broad-spectrum in-feed antibiotic commonly used in the swine industry. Weaned pigs (~21 d of age) were allotted to pens based on initial BW and fed a common starter diet for 4 d. Pens were then blocked by BW and allotted to dietary treatments in a completely randomized block design. Dietary treatments were arranged in a 2 × 3 factorial consisting of combinations of CTC (none vs. 400 mg/kg from days 0 to 42) and DFM (0 vs. 0.05% DFM 1 vs. 0.05% DFM 2). Fecal samples were collected from three randomly selected pigs from each pen on days 0, 21, and 42 for E. coli isolation and AMR determination. Overall, pigs fed diets containing CTC had improved (P < 0.001) ADG, ADFI, and BW compared to those not fed CTC with no evidence for any effect of either DFM 1 or DFM 2. Regardless of CTC, inclusion of DFM 2 in diets improved (P < 0.05) ADFI from days 0 to 14 and on day 14 BW compared to diets that did not include DFM 2. The addition of CTC with or without DFMs to nursery pig diets increased (P < 0.05) the probability of AMR to tetracycline and ceftiofur of fecal E. coli isolates, but this resistance generally decreased (P < 0.05) over time. A decrease (P < 0.05) in AMR to ampicillin and tetracycline (TET) throughout the trial was observed, while resistance to ceftriaxone decreased (P < 0.020) from days 0 to 21 and increased from days 21 to 42 amongst dietary treatments regardless of CTC or DFM inclusion in the diet. A CTC × DFM × day interaction (P < 0.015) was observed for streptomycin, whereby from days 21 to 42 AMR increased in diets containing either CTC or DFM 1 alone, but the combination decreased resistance. There was no evidence for any effect of DFMs on AMR of fecal E. coli isolates to any other antibiotics evaluated. In conclusion, therapeutic levels of added CTC with or without DFM inclusion improved nursery pig performance, but increased AMR of fecal E. coli isolates to TET and ceftiofur. A moderate improvement in intake and day 14 BW was observed when DFM 2 was included in the diet with or without CTC, but, except for streptomycin, there was no evidence that added dietary DFMs affected resistance of fecal E. coli to antibiotics.

Indexed as

Drug Resistance, BacterialAnimal FeedAnimal Nutritional Physiological PhenomenaAnimalsAnti-Bacterial AgentsChlortetracyclineDietEscherichia coliFecesMaleSwineWeaningAnti-Bacterial AgentsChlortetracycline

Identifiers

PMID30358839
PMCPMC6276563
OpenAlexW2898233596

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.